Coronary Disease: all 2,867 studies

Page 25 of 29. Open to participants first (309), then studies with results posted, then the rest; newest registration first within each.

• MDCT of the Coronary Arteries in Heart Transplanted PatientsCompletedNCT00403299Not applicable
• Evaluating the Association Between Pericardial Fat and Coronary Heart Disease - Ancillary to MESACompletedNCT00402922
• Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)CompletedNCT00402636Phase 4
• SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in EuropeCompletedNCT00402272Phase 4
• Effect of Remote Ischemic Preconditioning in Patient Undergoing Cardiac Bypass SurgeryCompletedNCT00397163Phase 1
• Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)CompletedNCT00396110
• Stem Cell Therapy to Improve Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting (CABG)Status unknownNCT00395811Phase 1/2
• P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent RestenosesCompletedNCT00393315Phase 2
• Limus Eluted From A Durable Versus ERodable Stent CoatingCompletedNCT00389220Not applicable
• Comparison of Cypher Select and Taxus Express Coronary StentsCompletedNCT00388934Phase 4
• PET and Recovery Following Revascularization (PARR 2)CompletedNCT00385242Phase 3
• EPC by Intracoronary Injection in Patients With Chronic Stable AnginaStatus unknownNCT00384514Phase 2
• Comparison of Screening Tools for Coronary Artery DiseaseStatus unknownNCT00383955
• The Effect of Beer, Red Wine and Fruit Juice on Blood Vessel Function in Persons With Cardiovascular DiseaseCompletedNCT00382551Early Phase 1
• Catheter-Based Treatment of Cardiovascular DiseaseCompletedNCT00380016Not applicable
• Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic GroupsCompletedNCT00377702
• Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary SyndromeCompletedNCT00373451Phase 4
• Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD StudyCompletedNCT00371098Phase 2/3
• Coronary Stenting and Coronary Bypass Grafting at the Same Time in a Specialty Built Operating RoomCompletedNCT00366015Not applicable
• Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican IndividualsCompletedNCT00365235
• The Association of Platelet Function and Endothelial Function of the Brachial ArteryCompletedNCT00363818
• The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or DiabetesCompletedNCT00360217Not applicable
• DARE: Diabetes in cArdiac REhabilitationCompletedNCT00354237Not applicable
• WENBIT - Western Norway B Vitamin Intervention TrialCompletedNCT00354081Phase 3
• Comparison of Cardiac Computed Tomography for the Detection of Coronary Artery Disease With Nuclear Stress TestCompletedNCT00352937
• Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)CompletedNCT00350454Phase 4
• Influence Of Omeprazole On The Anti-Platelet Action Of ClopidogrelCompletedNCT00349661Phase 3
• A Study of Computed Tomography (CT) for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest PainCompletedNCT00348569Not applicable
• Improving Cardiac Rehabilitation Participation in Women and MenCompletedNCT00336830Phase 3
• Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary AngiographyWithdrawnNCT00335101Phase 4
• The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent RestenosisCompletedNCT00332397Phase 4
• The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and HypercholesterolemiaCompletedNCT00329069Not applicable
• A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target LevelsCompletedNCT00327691Phase 4
• Efficacy of FX06 in the Prevention of Myocardial Reperfusion InjuryCompletedNCT00326976Phase 2
• Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise CapacityWithdrawnNCT00326690Not applicable
• Long-term Outcomes of Patients After Coronary Bifurcation StentingCompletedNCT00325884
• A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)CompletedNCT00322569Phase 3
• Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)TerminatedNCT00322543Phase 3
• Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous RegimenTerminatedNCT00320229Phase 4
• Heart and Estrogen-Progestin Replacement Study (HERS)CompletedNCT00319566Phase 3
• Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary SyndromeCompletedNCT00317395Phase 2
• RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)WithdrawnNCT00317343
• Coronary Bypass Surgery Trial: Complete Arterial Revascularization and Conventional Coronary Artery SurgeryTerminatedNCT00317265Not applicable
• A Study to Determine the Effect of Bi-Ventricular Pacing on Cardiac Hemodynamics After Coronary Artery Bypass GraftCompletedNCT00316368Phase 1
• Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary BypassTerminatedNCT00316212Phase 2
• The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent SystemCompletedNCT00314275Not applicable
• Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery DiseaseCompletedNCT00312052Phase 2
• Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CTCompletedNCT00311038Phase 2
• Impact of Patient-Prosthesis-Mismatch on Coronary Flow ReserveCompletedNCT00310947
• Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program ParticipantsCompletedNCT00308633
• Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet InhibitionCompletedNCT00302913Not applicable
• Effect of Folic Acid Treatment in Coronary Artery DiseaseStatus unknownNCT00300352Phase 2
• ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical InvestigationCompletedNCT00300131
• A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary StentCompletedNCT00299026Phase 2
• Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)CompletedNCT00298909Phase 4
• A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer LesionsCompletedNCT00297804Phase 2/3
• Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary RevascularizationCompletedNCT00297661Phase 4
• T Wave Alternans in HemodialysisCompletedNCT00296543
• Multi Detector-Row Computed Tomography (MDCT) Calcium Score of Heart Transplanted PatientsCompletedNCT00294853Not applicable
• TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting StentCompletedNCT00292474Phase 2/3
• A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous InterventionCompletedNCT00291902Phase 2
• Cell Therapy for Coronary Heart DiseaseTerminatedNCT00289822Phase 2
• Long-term Mortality in Diabetics Undergoing Major SurgeryCompletedNCT00286572
• Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)WithdrawnNCT00286559Phase 1/2
• Novel Method to Diagnose Acute Myocardial IschemiaCompletedNCT00285922
• The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-CholesterolCompletedNCT00283335Phase 3
• Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart DiseaseCompletedNCT00282360Phase 4
• Role of Epicardial Adipose Tissue in Coronary Artery DiseaseStatus unknownNCT00279227
• Inflammation and Coronary Artery Disease: Role of AT1-Receptor AntagonismCompletedNCT00274144Phase 4
• SB-480848 In Subjects With Coronary Heart DiseaseCompletedNCT00269048Phase 2
• Cardiovascular Risk Factor Management in HIV InfectionCompletedNCT00264394Phase 4
• Investigation of Genetic Risk of Cardiovascular Disease in Prospective Cohort StudyStatus unknownNCT00262691
• Effect of BNP (Brain Natriuretic Peptides) on Endothelial Dysfunction Induced by Coronary AngioplastyStatus unknownNCT00262574Phase 4
• Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)CompletedNCT00262054Phase 4
• Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial IschemiaCompletedNCT00260338Phase 1/2
• Risk Factors of Individuals With Coronary Artery DiseaseStatus unknownNCT00260104
• Graft Patency in Beating Heart Vs. Conventional CABG Using Cardiac CTStatus unknownNCT00259493Not applicable
• Sirolimus-Eluting Stents for Chronic Total Coronary OcclusionsCompletedNCT00258596Phase 3
• The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)CompletedNCT00250380
• Determinants of Cardiac Risk Factor Modification in Latinos With Coronary Artery DiseaseCompletedNCT00248859
• Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary ArteriesCompletedNCT00248066Phase 2
• Cerebral Artery Stenosis, Coronary Artery Disease and ArrhythmiaStatus unknownNCT00247533Phase 4
• DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)CompletedNCT00243438
• Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)CompletedNCT00242944Phase 4
• Coronary Heart Disease Incidence: Depression & Inflammation RiskCompletedNCT00241774
• Epidemiology of Depression and Heart Failure in AgingCompletedNCT00241761
• Soy Food and Coronary Heart Disease in WomenCompletedNCT00241735
• Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart DiseaseCompletedNCT00235950Phase 4
• Vascular Response to Isoproterenol and β2 Adrenergic Receptor PolymorphismsCompletedNCT00226551Not applicable
• Impact of Medical and Surgical Therapy on Functional Mitral RegurgitationCompletedNCT00224809Not applicable
• Reassessment Strategy in the Diagnosis of Coronary Heart Disease in ElderlyTerminatedNCT00224575Not applicable
• Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.CompletedNCT00222261Phase 4
• Role of Left Ventricular Pacing SiteStatus unknownNCT00221780Not applicable
• Acarbose and Secondary Prevention After Coronary StentingCompletedNCT00221156Phase 3
• Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery SurgeryCompletedNCT00209521Phase 2
• A Randomized Controlled Trial to Improve Medication Compliance Among Patients With Coronary Heart DiseaseCompletedNCT00208832Not applicable
• Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?CompletedNCT00205166Not applicable
• Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)CompletedNCT00202904Phase 4
• Diagnosis of Coronary Artery Disease in High Risk Diabetic PatientsTerminatedNCT00202670
• Training at Different Intensities in Coronary Artery Disease -Effects on Myocardial FunctionCompletedNCT00201591Not applicable

← Coronary Disease overview